BG101787A - Aprotinine options having improved properties - Google Patents

Aprotinine options having improved properties

Info

Publication number
BG101787A
BG101787A BG101787A BG10178797A BG101787A BG 101787 A BG101787 A BG 101787A BG 101787 A BG101787 A BG 101787A BG 10178797 A BG10178797 A BG 10178797A BG 101787 A BG101787 A BG 101787A
Authority
BG
Bulgaria
Prior art keywords
aprotinine
options
improved properties
improvedenzymoinhibiting
andto
Prior art date
Application number
BG101787A
Other languages
Bulgarian (bg)
English (en)
Inventor
Werner Schroeder
Soren Bjorn
Kjeld Norris
Viggo DINNES
Niels CHRISTENSEN
Leif Norkskov-Lauritsen
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG101787A publication Critical patent/BG101787A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG101787A 1996-07-25 1997-07-22 Aprotinine options having improved properties BG101787A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19629982A DE19629982A1 (de) 1996-07-25 1996-07-25 Aprotinin-Varianten mit verbesserten Eigenschaften

Publications (1)

Publication Number Publication Date
BG101787A true BG101787A (en) 1998-10-30

Family

ID=7800774

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101787A BG101787A (en) 1996-07-25 1997-07-22 Aprotinine options having improved properties

Country Status (37)

Country Link
US (2) US6482798B2 (fr)
EP (1) EP0821007B1 (fr)
JP (1) JPH10101700A (fr)
KR (1) KR980009283A (fr)
CN (1) CN1172116A (fr)
AR (1) AR008783A1 (fr)
AT (1) ATE260975T1 (fr)
AU (2) AU2870197A (fr)
BG (1) BG101787A (fr)
BR (1) BR9704068A (fr)
CA (1) CA2207071A1 (fr)
CO (1) CO4890857A1 (fr)
CZ (1) CZ236797A3 (fr)
DE (2) DE19629982A1 (fr)
DZ (1) DZ2276A1 (fr)
EE (1) EE9700177A (fr)
ES (1) ES2217350T3 (fr)
HN (1) HN1997000094A (fr)
HR (1) HRP970384A2 (fr)
HU (1) HUP9701290A3 (fr)
ID (1) ID17508A (fr)
IL (1) IL121361A0 (fr)
MA (1) MA24279A1 (fr)
NO (1) NO973426L (fr)
NZ (1) NZ328402A (fr)
PE (1) PE92298A1 (fr)
PL (1) PL321341A1 (fr)
RU (1) RU2197983C2 (fr)
SG (1) SG71714A1 (fr)
SK (1) SK101997A3 (fr)
SV (1) SV1997000068A (fr)
TN (1) TNSN97130A1 (fr)
TR (1) TR199700688A2 (fr)
TW (1) TW480271B (fr)
UA (1) UA55380C2 (fr)
YU (1) YU31697A (fr)
ZA (1) ZA976585B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19725014A1 (de) * 1997-06-13 1998-12-17 Bayer Ag Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten
US6974188B2 (en) * 2003-08-13 2005-12-13 Cosco Management, Inc. Chair with pivotable chair back
US20060218667A1 (en) * 2004-10-12 2006-09-28 Vojdani Fakhrieh S Plant-produced recombinant aprotinin and aprotinin variants
WO2006042327A2 (fr) * 2004-10-12 2006-04-20 Large Scale Biology Corporation Aprotinine de recombinaison d'origine vegetale et variants d'aprotinine
USD533000S1 (en) * 2005-02-18 2006-12-05 Atico International Usa, Inc. Connector housing of an anti-pinching device of a folding chair
MX2007010113A (es) * 2005-02-18 2007-12-07 Angiochem Inc Polipeptidos de aprotinina para transportar un compuesto a traves de la barrera hematoencefalica.
WO2008077478A1 (fr) * 2006-12-22 2008-07-03 Bayer Schering Pharma Aktiengesellschaft Préparation et utilisation de variants du domaine 2 de kunitz du gène de la bikunine placentaire humaine
WO2008110301A1 (fr) * 2007-03-13 2008-09-18 Bayer Schering Pharma Aktiengesellschaft Variants d'aprotinine à propriétés améliorées
DE102007056231A1 (de) 2007-09-08 2009-03-12 Bayer Healthcare Ag Herstellung und Verwendung von Varianten humander Kunitz-Typ Protease-Inhibitoren (hKTPI)
BRPI1103921A2 (pt) 2011-08-17 2013-08-06 Mahle Metal Leve Sa camisa de cilindro e liga de ferro fundido
EP4460509A1 (fr) * 2022-01-05 2024-11-13 Helix Nanotechnologies Inc Compositions comprenant une séquence prepro de facteur alpha et leurs utilisations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560584B2 (en) 1983-07-28 1987-04-09 Bayer Aktiengesellschaft Homologues of aprotinin
US4595974A (en) * 1984-09-10 1986-06-17 Burroughs Corporation Base drive circuit for a switching power transistor
GB2208511A (en) 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
US5591603A (en) 1987-08-28 1997-01-07 Novo Nordisk A/S Process for preparing aprotinin and aprotinin analogs in yeast cells
DK225488D0 (da) * 1988-04-26 1988-04-26 Novo Industri As Polypeptid
DK463887D0 (da) 1987-09-07 1987-09-07 Novo Industri As Gaerleader
DK105489D0 (da) 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
US5231010A (en) 1989-09-13 1993-07-27 Bayer Aktiengesellschaft Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
DE3930522A1 (de) * 1989-09-13 1991-03-21 Bayer Ag Rekombinante aprotinin-varianten - gentechnisches verfahren zur mikrobiellen herstellung von homogen prozessierten aprotinin-varianten sowie die therapeutische anwendung derselben
IL99585A0 (en) * 1990-10-01 1992-08-18 Novo Nordisk As Aprotinin analogues,their production and pharmaceutical compositions containing them
US5747449A (en) * 1992-07-13 1998-05-05 Corvas International, Inc. Bovine pancreatic trypsin inhibitor derived inhibitors of factor XA
KR100199565B1 (ko) * 1994-08-19 1999-06-15 차동천 승화형 감열전사 기록용 수용지의 중간층 제조방법

Also Published As

Publication number Publication date
EE9700177A (et) 1998-02-16
ATE260975T1 (de) 2004-03-15
NO973426D0 (no) 1997-07-24
DZ2276A1 (fr) 2002-12-18
ID17508A (id) 1998-01-08
US6482798B2 (en) 2002-11-19
HUP9701290A2 (hu) 1999-06-28
BR9704068A (pt) 1999-01-05
CN1172116A (zh) 1998-02-04
CO4890857A1 (es) 2000-02-28
DE19629982A1 (de) 1998-01-29
UA55380C2 (uk) 2003-04-15
AU762041B2 (en) 2003-06-19
NZ328402A (en) 1999-03-29
TW480271B (en) 2002-03-21
IL121361A0 (en) 1998-01-04
HU9701290D0 (en) 1997-09-29
SV1997000068A (es) 1998-07-09
HUP9701290A3 (en) 2000-08-28
DE59711356D1 (de) 2004-04-08
EP0821007B1 (fr) 2004-03-03
ZA976585B (en) 1998-02-03
US20030096752A1 (en) 2003-05-22
KR980009283A (ko) 1998-04-30
HRP970384A2 (en) 1998-04-30
AU5178701A (en) 2001-09-06
AR008783A1 (es) 2000-02-23
YU31697A (sh) 1999-07-28
EP0821007A3 (fr) 1998-11-18
MX9705605A (es) 1998-08-30
JPH10101700A (ja) 1998-04-21
NO973426L (no) 1998-01-26
SK101997A3 (en) 1998-03-04
TNSN97130A1 (fr) 2005-03-15
CZ236797A3 (cs) 1998-02-18
US20020103334A1 (en) 2002-08-01
EP0821007A2 (fr) 1998-01-28
AU2870197A (en) 1998-02-05
PE92298A1 (es) 1999-02-13
SG71714A1 (en) 2000-04-18
ES2217350T3 (es) 2004-11-01
MA24279A1 (fr) 1998-04-01
PL321341A1 (en) 1998-02-02
TR199700688A2 (xx) 1998-02-21
CA2207071A1 (fr) 1998-01-25
HN1997000094A (es) 1997-12-26
RU2197983C2 (ru) 2003-02-10

Similar Documents

Publication Publication Date Title
MXPA02004666A (es) Gelatinas recombinantes.
BG102781A (en) Isolated dimer fibroblastactivation protein alpha and its application
WO1996017072A3 (fr) Vecteurs d'alphavirus de recombinaison
MXPA01007710A (es) Agente de secado por congelacion que contiene paramilon, su produccion y uso.
DE69534778D1 (en) Cathepsin-02-protease
BG104943A (en) Biodegradable sustained-release alginate gels
ID23374A (id) Halogenopirimidin
GB9425109D0 (en) Novel fusarium isolate and lipases, cutinases and enzyme compositions derived therefrom
ZA979202B (en) Conditioning shampoo compositions having improved silicone deposition.
GR970300016T1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
ZA974585B (en) Sizing compositions.
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
HUP0004085A3 (en) Novel 3,6-hemiketals from the class of 9a-azalides
IL128500A0 (en) Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta (b) benzofurans
MX9806041A (es) Proteina purificada sr-p70.
YU31697A (sh) Varijante aprotinina sa poboljšanim svojstvima
IL139604A0 (en) Novel peptides
DE69737457D1 (de) O-fukosyltransferase
BG104373A (en) Polymorphous forms of dofetilide
BG104707A (en) Caspase-8 interacting proteins
ZA977491B (en) Use of polyhydroxycarboxylamides as EP additives.
ZA987660B (en) Novel tissue-specific calpains, their preparation and use.
GB2325466A (en) Nucleotide sequence from goat liver
BG102937A (en) Zona pelucida proteins as contraceptives
ZA9610510B (en) Novel peptides, the preparation and use thereof.